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Transforming growth factors- (TGF-s) signal through type I and type II serine–threonine kinase receptor complexes. During ligand
binding, type II receptors recruit and phosphorylate type I receptors, triggering downstream signaling. BAMBI [bone morphogenetic
protein (BMP) and activin membrane-bound inhibitor] is a transmembrane pseudoreceptor structurally similar to type I receptors but
lacks the intracellular kinase domain. BAMBI modulates negatively pan-TGF- family signaling; therefore, it can be used as an instru-
ment for unraveling the roles of these cytokines in the adult CNS.BAMBI is expressed in regions of the CNS involved in pain transmission
and modulation. The lack of BAMBI in mutant mice resulted in increased levels of TGF- signaling activity, which was associated with
attenuation of acute pain behaviors, regardless of the modality of the stimuli (thermal, mechanical, chemical/inflammatory). The noci-
ceptive hyposensitivity exhibited by BAMBI/mice was reversed by the opioid antagonist naloxone. Moreover, in a model of chronic
neuropathic pain, the allodynic responses ofBAMBI/mice also appeared attenuated through amechanism involving -opioid recep-
tor signaling. BasalmRNA and protein levels of precursor proteins of the endogenous opioid peptides proopiomelanocortin (POMC) and
proenkephalin (PENK) appeared increased in the spinal cords ofBAMBI/. Transcript levels of TGF-s and their intracellular effectors
correlated directly with genes encoding opioid peptides, whereas BAMBI correlated inversely. Furthermore, incubation of spinal cord
explants with activin A or BMP-7 increased POMC and/or PENKmRNA levels. Our findings identify TGF- family members as modula-
tors of acute and chronic pain perception through the transcriptional regulation of genes encoding the endogenous opioids.
Introduction
The transforming growth factor- (TGF-) superfamily of cyto-
kines includes activins, TGF-s, and bone morphogenetic pro-
teins (BMPs). TGF-s signal through heteromeric combinations
of type I receptors, also termed activin-like kinases (ALK), and
type II receptors, both of which are serine/threonine kinases
(Wrana et al., 1994). Ligand binding leads to downstream prop-
agation of the signal through canonical phosphorylation of Smad
proteins, which are translocated into the nucleus to regulate the
transcription of TGF- target genes (Feng and Derynck, 2005;
Massague´ et al., 2005), as well as through noncanonical signaling,
notably via TGF--activated kinase 1 (TAK1) (Yamaguchi et al.,
1995; Zhang, 2009). TGF- signaling is modulated by BAMBI
(BMP and activin membrane-bound inhibitor), a transmem-
brane protein that is structurally similar to type I receptors but
lacks the intracellular kinase domain. BAMBI acts as a pseudore-
ceptor that inhibits pan-TGF- family signaling by preventing
the formation of active receptor complexes (Onichtchouk et al.,
1999; Yan et al., 2009). BAMBI can also function as a positive
regulator of the Wnt/-catenin pathway (Lin et al., 2008).
Little is known about the physiological functions regulated by
BAMBI or the pathological consequences of an unbalance be-
tween BAMBI and TGF-s. During embryogenesis, BAMBI
would act as a negative feedback regulator of BMP signaling
(Onichtchouk et al., 1999; Tsang et al., 2000), in a context of
cooperative function within the BMP-4 synexpression group
(Grotewold et al., 2001; Karaulanov et al., 2004). However, dele-
tion of the BAMBI gene has no apparent phenotypic conse-
quences affecting embryonic development (Chen et al., 2007).
BAMBI deregulation has been involved in the pathogenesis of
various human pathologies, such as tumor progression and met-
astatic capability (Togo et al., 2008; Fritzmann et al., 2009; Khin
et al., 2009), pathological fibrosis (Seki et al., 2007; Harada et al.,
2009), and metaplastic bone formation (Kitazawa et al., 2005).
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The biological processes regulated by the TGF- family of
cytokines in the rodent developing nervous system have been
extensively studied (Bo¨ttner et al., 2000). In the adult CNS, more
or less strong signals for several members and receptors of the
TGF- family are still detectable (Funaba et al., 1997; Mehler et
al., 1997; Bo¨ttner et al., 2000; Unsicker and Strelau, 2000; Chen et
al., 2003; Fan et al., 2003; Mikawa et al., 2006), supporting a role
as modulators of neural functions in the adulthood. Among the
functions exerted by TGF-s in the mature CNS, neuroprotec-
tion, neurogenesis, and repair process orchestration are best
studied (Brionne et al., 2003; Israelsson et al., 2006; Vivien and
Ali, 2006; Ageta et al., 2008). Recently, it has been reported that
TGF-1 alleviates neuropathic pain in rats, and the suggested
mechanism involves an inhibitory effect on the spinal cord in-
flammatory response to nerve injury and a neuroprotective
effect on damaged neurons (Echeverry et al., 2009).
In this work, we generated mutant mice, lacking the TGF-
signaling inhibitor BAMBI, to investigate whether the TGF-
family is involved in nociceptive processing under physiological
and pathological conditions. Herein, we show that BAMBI is ex-
pressed inmicenociception-relevantareasandthat targeteddeletion
of BAMBI results in attenuation of both acute pain behaviors and
neuropathic pain development after nerve injury. The mechanism
involves the transcriptional regulation by members of the TGF-
family of genes encoding endogenous opioid peptides.
Materials andMethods
Animals
The experiments were performed inmalemice, housed in a room kept at
22°C with and exposed for their whole lifespan to an inverted 12 h light/
dark cycle (dark from 8:00 A.M. to 8:00 P.M.).
Food and water were provided ad libitum. This
study was approved by the Cantabria Univer-
sity Institutional Laboratory Animal Care and
UseCommittee, and the experimentswere per-
formed in accordance with the Declaration of
Helsinki and the European Communities
Council Directive (86/609/EEC) and the guide-
lines of the Committee for Research and Ethical
Issues of International Association for the Study
of Pain (Zimmermann, 1983). Every effort was
made to minimize the number of animals used
and their suffering.
Generation of BAMBI/mice
Homologous recombination in embryonic
stem cells was used to create a 129SvJ 
C57BL/6 mouse line, in which exons 2 and 3 of
the BAMBI gene were deleted (Fig. 1A). The
remaining exon 1 contains the 5 untranslated
region and the first 14 amino acids, which are
part of the signaling sequence characteristic of
membrane-targeted or -secreted proteins.Mu-
tant mice were backcrossed with C57BL/6
up to the F6 generation. Interbreeding of
BAMBI/mice resulted in homozygous mu-
tant mice. The experiments were performed in
adult (14–16 weeks) BAMBI/, BAMBI/,
and BAMBI/ mice. Genotyping was per-
formed on genomicDNA extracted from tissue
punched from the ear by PCR, following stan-
dard protocols with TaqDNA Polymerase (In-
vitrogen) (Fig. 1B). The primers were designed
to amplify a 398 bp fragment containing parts
of the deleted region (forward, TGTGAT-
AGCGGTTCCCATTGC; reverse, CCAGATA-
AAAGTGCTCCTGTCAGC) for the wild-type
allele and a 524 bp fragment containing part of
the neomycin cassette (forward, 5-TTCGCCAATGACAAGACGCT-
GG-3; reverse, 5-GGACACAAAGAACCCTGGGAAAG-3) for the tar-
geted allele. The existence of BAMBI transcripts in the CNS of wild-type
mice as well as its absence in BAMBI/mice was confirmed by reverse
transcription (RT)-PCR analyses (Fig. 1C). An increase in TGF- family-
mediated signaling inmutantmice, comparedwith their wild-type litter-
mates, was reflected by the increased expression of phosphorylated
Smad-1 and Smad-2 proteins observed in the brain cortex and spinal
cord by Western blot analyses (Fig. 1D).
General behavior studies
Behavioral studies were performed in 14-week-old mice (n  8–12 per
group) by observers blinded to the genotypes of the animals. Mice sen-
sorimotor functions were evaluated in a battery of tests assessing motor
activity, sensorimotor reflexes, equilibrium, and coordination as de-
scribed previously (Martínez-Cue´ et al., 2005). Mice performed the be-
havioral tests during their activity (dark) phase, under dim red light.
Acute pain behavior studies
The warm-water tail-flick test was performed by immersing the tip of the
tail (2–3 cm) into the water. The time it took to remove the tail from
the water heated to 45, 47, and 49°C was measured (cutoff time, 60 s).
In the hotplate test, mice were placed on a 50 or 52°C hotplate, and the
delay to hindpaw licking and jump were recorded (cutoff time, 120 s). In
the Formalin test, mice received a 20 l intraplantar injection of a 2%
Formalin solution in the left hindpaw, and the time spent licking the paw
was recorded within the first 5 min (first phase) and from 20 to 30 min
after injection (second phase). Themechanical withdrawal threshold test
was performed by applying an ascending series of calibrated von Frey
hairs to the plantar surface of each hindpaw until a withdrawal response
was observed. The results are expressed as percentage of pawwithdrawals
in response to stimuli of increasing strength (0.1–10 g) applied five times
Figure 1. Targeted disruption of the BAMBI gene by homologous recombination. A, Gene-targeting strategy. Top, Wild-type
BAMBI locus showing exons 1–3 (filled boxes). Bottom, Targeting vector in which exons 2 and 3were replacedwith the neomycin
(neo) resistance marker. Arrows indicate the position of the primers used for genotyping. B, PCR analysis of genomic DNA from
BAMBI/, BAMBI/, and BAMBI/mice. C, RT-PCR analysis of BAMBImRNA expression in the brain cortices (Cx) and spinal
cords (Sc) of BAMBI/ and BAMBI/mice. GAPDH, Glyceraldehyde-3-phosphate dehydrogenase. D, Representative Western
blot of phosphorylated Smad1 and Smad2 proteins in the spinal cord of BAMBI/ and BAMBI/mice.
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each, and 50% of responses is considered the mechanical withdrawal
threshold (in grams). All tests were performed with 8–12 animals per
group.
Chronic neuropathic pain behavior studies
Sciatic nerve crush injury. To induce the development of neuropathic
pain,micewere subjected to sciatic nerve crush injury (Bester et al., 2000)
under inhalation anesthesia with isoflurane (induction, 3%; surgery,
1.5%). The left common sciatic nerve was exposed via blunt dissection
through the biceps femoris muscle. The nerve was isolated from sur-
rounding connective tissue at themidthigh level and crushed for 7 s using
smooth forceps. The muscle and skin layers were closed under aseptic
conditions. Control cohorts (sham-operated mice) underwent the same
surgical procedure, but the nerve was exposed and left intact. The time
course of neuropathic pain development, manifested as mechanical hy-
persensitivity and tactile allodynia (painful responses to normally innoc-
uous stimuli), was assessed by the application of von Frey filaments to the
plantar surface of the hindpaw before surgery and at days 3, 7, 10, 14, and
18 after crush injury of the sciatic nerve. A series of mice, subjected to
sciatic injury for 14 d, were treated with either the nonselective opioid
antagonist naloxone (NLX) (1mg/kg; Sigma) or the selective antagonists
of -opioid [-funaltrexamine (-FNA); 15 mg/kg; Tocris Bioscience],
-opioid (naltrindole; 10 mg/kg; Tocris Bioscience), and -opioid [nor-
binaltorphimine (nor-BNI); 10 mg/kg; Tocris Bioscience] receptors be-
fore measuring mechanical responsiveness to von Frey filaments.
Spared nerve injury model of neuropathic pain. An additional set of
experiments was performed using the “spared nerve injury” (SNI)model
(Decosterd and Woolf, 2000) of neuropathic pain. Mononeuropathy
was induced according to the method originally described in the rat
(Decosterd andWoolf, 2000) and reproduced in themouse (Bourquin et
al., 2006). Mice were anesthetized with isoflurane (induction, 3%; sur-
gery, 1.5%). The left common sciatic nerve was blunt dissected through
the biceps and femoris muscle, freed of connective, and the three periph-
eral branches (sural, common peroneal, and tibial nerves) of the sciatic
nerve were exposed. The tibial and commonperoneal nerves were ligated
and transacted together. The sural nerve was carefully preserved by
avoiding any nerve stretch or nerve contact with surgical tools. Themus-
cle and skin layers were closed under aseptic conditions. Control cohorts
(sham-operated mice) underwent the same surgical procedure, but the
sciatic nerve was exposed and left intact. The time course of mechanical
allodynia-like behavior wasmeasured in the non-injured sural nerve skin
territory from days 1 to 15 after surgery by the application of von Frey
filaments.
In situ hybridization
In situ hybridization studies were performed, as described previously
(Zuzarte-Luís et al., 2004), in paraformaldehyde-fixed CNS coronal sec-
tions (100 m) using digoxigenin-labeled antisense RNA probes of the
BAMBI, ALK-3/BMPRIa, ALK-4/ActRIb, and ALK-6/BMPRIb genes.
The specificity of labeling was established using sense riboprobes. Reac-
tions were developed with BM Purple AP substrate (Roche).
Immunohistochemistry and immunofluorescent staining
Immunohistochemical staining was performed in formaldehyde-fixed,
paraffin-included spinal cord sections of 6 m thickness. Antigen re-
trieval was performed by heating the slides immersed in sodium citrate
buffer (10 mM sodium citrate and 0.05% Tween 20, pH 6.0) for 5 min in
a pressure boiler. Sections were incubated overnight at 4°C with a goat
anti-BAMBI polyclonal primary antibody (1:25; R & D Systems),
followed by a 60min incubation at room temperature with a peroxidase-
conjugated secondary antibody. Slides were developed using diamino-
benzidine (Sigma) as chromogen. Omission of primary or secondary
antibodies completely abolished specific staining.
For immunofluorescent staining, the animals were perfused, under
deep pentobarbital anesthesia, with 3.7% paraformaldehyde in PBS
(freshly prepared). Dorsal horn spinal cord and dorsal root ganglion
fragments were removed from 300m sections and washed in PBS. Each
tissue fragment was transferred to a drop of PBS on a siliconized slide,
and squash preparations of dissociated neurons and glia were performed
following the procedure reported previously (Pena et al., 2001). Then,
the samples were sequentially treated with 0.5% Triton X-100 in PBS for
30 min, PBS for 10 min two times, and 0.01% Tween 20 in PBS for 10
min. The samples were incubated overnight at 4°C with the following
primary antibodies: mouse monoclonal antibody anti-BAMBI (1:50;
Abnova) and rabbit anti-glial fibrillary acid protein (GFAP) polyclonal
antibody (1:200; Dako), followed by 60min incubation at room temper-
ature in the specific secondary antibodies conjugated with FITC or Texas
Red (Jackson ImmunoResearch). 4,6-Diamino-2-phenylindole dihy-
drochloride (DAPI) was also used as a nuclear counterstain (1:1000;
Sigma). Omission of primary or secondary antibodies completely abol-
ished specific staining.
RNA isolation, cDNA synthesis, and real-time PCR
Total RNA from tissue was obtained by TRIzol extraction (Invitrogen).
One microgram of the isolated RNA was reverse transcribed into cDNA
with an RT-PCR kit (Fermentas), according to the instructions of the
manufacturer. Quantitative, real-time PCR was conducted on an MX-
3000P Stratagene thermocycler using specific TaqMan expression assays
(Applied Biosystems) and Universal PCR Master Mix (Takara). Results
were normalized to the housekeeping genes glyceraldehyde-3-phosphate
dehydrogenase or ribosomal 18S subunit expression and measured in
parallel in each sample. Results are expressed as Ct. Duplicate tran-
script levels were determined in three independent experiments.
Western blot
Whole-cell lysates were prepared from the cerebral cortices, hip-
pocampus, and spinal cords. Equal amounts of whole-cell protein
were resolved on 12.5% SDS-PAGE and transferred to a polyvinyli-
dene difluoride membrane. The following primary antibodies were
used: anti-phospho-Smad-2 (1:1000; catalog #3101; Cell Signaling
Technology); anti-phospho-Smad-1 (1:1000; a gift from Dr. C. H. Heldin,
Ludwig Institute for Cancer Research, Uppsala University, Uppsala,
Sweden), and anti-proopiomelanocortin (POMC) (1:1000; ab32893;
Abcam). ImmunoreactivitywasdetectedwithGEHealthcareECLAdvanced
detection reagents and visualized by GE Healthcare Hyperfilm-ECL. Films
were scanned, and optical densities were determined by using the Scion
Image software (Scion Corporation).
Radioimmunoassay
After decapitation, the spinal cords of the mice were extracted by hydro-
extrusion and immediately frozen in liquid nitrogen. Peptides were ex-
tracted as described. Radioimmunoassay (RIA) of Leu-enkephalin and
Dynorphin A was performed using commercial kits (Phoenix Pharma-
ceuticals), following the recommendations of the manufacturer. Each
sample was assayed in triplicate.
Spinal cord explants stimulation
Micewere anesthetized anddecapitated. The spinal cordwas extracted by
hydro-extrusion (De Sousa and Horrocks, 1979) and dissected through
the middle line to obtain two hemi-spinal cords. Each hemi-spinal cord
was placed onto a Millicell-CM culture plate (Millipore Corporation)
and inserted into a six-well plate. Spinal cords were incubated for 1 h in
1.5 ml of DMEM (Sigma) with or without recombinant BMP-7 (20 ng/
ml; R&D Systems) or activin (20 ng/ml; R&D Systems), in a humidified
atmosphere of 5% CO2, at 37°C. Each hemi-spinal cord served as the
control for its complementary half. RNA isolation, retrotranscription to
cDNA, and real-time PCR were performed as described previously.
Data analysis and statistics
Behavioral experiments were conducted blindly as to the genotype of the
mice. All results are presented as mean  SEM. Statistical differences
between genotypes were analyzed with one-way, two-way, or repeated-
measures ANOVA, followed by Bonferroni’s test. Individual time points
were analyzed with unpaired t test. For all analyses, p 0.05 was consid-
ered significant.
Results
Regional distribution of BAMBI in the nervous system
Representative in situ hybridization images at the mesencephalic
and spinal cord levels are presented in Figure 2, A and B. Strong
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labeling levels ofBAMBIwere detected in the cingulate, retrosple-
nial and piriform cortex, the CA1, CA2, and CA3 hippocampal
fields, the dentate gyrus, the posterior thalamic nuclei, the lateral
hypothalamic area, the substantia nigra, the ventral tegmental
area, the periaqueductal gray matter, and the dorsal horn of the
spinal cord. The expression of BAMBI in dorsal horn overlaps
with several type I receptors for TGF- family members, such as
ALK-3, ALK-4, and ALK-6 (Fig. 2C–E). Control experiments,
using sense riboprobes, showed no signal (data not shown).
As observed for BAMBI transcripts, immunohistochemical
staining evidenced the presence of BAMBI immunoreactivity in
the superficial layers of the spinal cord dorsal horn (Fig. 2F).
Immunofluorescence performed in squash preparations of dis-
sociated neurons and glia evidenced that BAMBI immunoreac-
tivity is located preferentially in neurons (Fig. 2G). High levels of
BAMBI immunoreactivity were also detected in virtually all dor-
sal root ganglion neurons (Fig. 2H,H	) but were absent in their
surrounding satellite glial cells. High-magnification confocal im-
munofluorescence images (Fig. 2H	) disclosed a peripheral ex-
pression pattern of BAMBI immunoreactivity, consistent with its
transmembrane localization.
Lack of BAMBI has no effect on general behavior
Mutant mice were fertile, appeared healthy, showed no apparent
phenotypic defects, and displayed longevity that was indistin-
guishable from wild-type littermates. Their sensorimotor abili-
ties, locomotor activity, and coordination, measured in the open
field and the rotarod tests, were similar to those ofwild-type (data
not shown).
Lack of BAMBI reduces basal nocifensive responses in
thermal, mechanical, and chemical/inflammatory tests
of acute pain
We examined the behavioral responses of BAMBI/ mice to
noxious thermal (n  12 per group), chemical/inflammatory
(n  8 per group), and mechanical (n  12 per group) stimuli
tests (Vierck, 2006). Two models of thermal nociception were
used: the warm-water tail-immersion test that examines spinal-
mediated responses, and the hotplate test that examines both
spinal and supraspinal-mediated responses. In the tail-immersion
test, BAMBI/mice experienced a significantly greater delay in
tail withdrawal than the wild-type mice at 45, 47, and 49°C (Fig.
3A). Furthermore, there was a gene-dosage dependence of the
response, because the reaction time of the BAMBI/ mice oc-
curred between wild-type and knock-out mice (Fig. 3B). The
delays in licking behavior and jumping fromahotplate set at 50°C
(Fig. 3C) and 52°C were also significantly longer in BAMBI/
mice than in their wild-type littermates.
The effect of BAMBI deletion on chemical pain behavior was
assessed in the Formalin test. Injection of Formalin into the hind-
paw induces a biphasic pain response; the first phase is thought to
result from direct activation of TRPA1 cation channel in primary
afferent sensory neurons, whereas the second phase has been
proposed to reflect the combined effects of afferent input and
activity-dependent sensitization of CNS neurons within the dor-
sal horn (Coderre et al., 1990; Tjølsen et al., 1992; McNamara et
al., 2007). Intradermal injection of Formalin into the hindpaw
produced the typical biphasic paw-licking behavior in wild-type
and BAMBI/mice; however BAMBI/mice showed a signif-
Figure 2. In situhybridization showing thedistribution of BAMBImRNA in the spinal cord (A) andbrain (B) and type I receptors ALK-4 (C), ALK-3 (D), andALK-6 (E)mRNA in the spinal cord. One-hundred-
micrometer coronal sectionswerehybridizedwithdigoxigenin-labeled riboprobes. Immunohistochemical stainingevidenced thepresenceofBAMBI immunoreactivity in the superficial layersof the spinal cord
dorsalhorn(F ).Representative immunofluorescenceimagesfromsquashpreparationsofdissociatedneuronsandgliafromdorsalhorn(G–G)anddorsal rootganglion(H–H).Thenucleiwerecounterstained
with DAPI (G,H ). BAMBI immunoreactivity (green)was detected in some neuronswithin dorsal horn (G) with negligible presence in astrocytes stained (red)with GFAP (G). In dorsal root ganglion, BAMBI
signalwas present in neurons (H) but absent in their surrounding satellite glial cells. Confocal high-magnification immunofluorescence images indicate a peripheral expression pattern of BAMBI immunore-
activity (H), consistentwith its transmembrane localization. HP, Hippocampus; PG,mesencephalic periaqueductal gray; DH, dorsal horn of the spinal cord.
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icantly reduced pain behavior during both the early (acute) and
the second (tonic) phases of the test (Fig. 3D).
In the von Frey test of mechanical sensitivity, which depends
on the firing of mechanosensitive A-fibers and polymodal
C-fibers, the hindpaw-withdrawal response to stimulation at
graded intensities of force was less pronounced in BAMBI/
mice than in the wild-type mice (Fig. 3E). The gene-dosage de-
pendence of the mechanically induced paw response was also
evident (Fig. 3F).
These results indicate the involvement of TGF-s in nocicep-
tive processing, regardless of the modality of the noxious stimuli
(thermal, mechanical, and chemical/inflammatory).
Lack of BAMBI attenuates the expression of neuropathic
pain responses
We assessed the potential involvement of BAMBI in chronic pain
behaviors in twomodels of neuropathic pain thatmimics periph-
eral nerve injury in humans: the crush injury of sciatic nerve
(Bester et al., 2000) and the spared nerve injury (Decosterd and
Woolf, 2000; Bourquin et al., 2006).
In the crush injury of sciatic nerve model, we evaluated the
nocifensive response to the hindpaw tactile mechanical stimula-
tion at graded intensities of stimuli for 18 d after crush (n  10
per group). Wild-type mice displayed a progressive and signifi-
cant decrease in the paw-withdrawal threshold, starting at day 7
and reaching the maximal allodynic response 14 d after crush.
ANOVA indicated that BAMBI/ mice were significantly less
sensitive to mechanical stimuli compared with the wild-type
group throughout the follow-up period (ANOVA; genotype:
F(1,90)  39.9, p  0.001; time: F(5,90)  48.9, p  0.001; geno-
type time: F(5,90) 6.8, p 0.001). In Figure 4 (top), we show
representative graphs showing the reduced nocifensive resp-
onses of BAMBI/mice to hindpaw mechanical stimulation, at
graded intensities of force on day 14 after injury compared with
their wild-type littermates (genotype: F(1,69)  80.7, p  0.001;
nerve injury: F(1,69) 97.1, p 0.001; genotype nerve injury:
F(1,69) 25.0, p 0.001).
In the spared nerve injurymodel of neuropathic pain (n 7–9
animals per group)BAMBI/mice also exhibited a lower degree
of mechanical allodynia than their wild-type littermates as indi-
cated two-way ANOVA (genotype: F(1,104)  90.8, p  0.001;
nerve injury: F(1,104) 199.3, p 0.001; genotypenerve injury:
F(1,104) 13.1, p 0.001) (Fig. 5).
The opioid antagonist naloxone reverses thermal and
mechanical hyposensitivity in BAMBI/mice
The presence of BAMBI transcripts in the dorsal horn of the
spinal cord and the periaqueductal gray matter, paradigmatic
areas inwhich the endogenous opioidergic systemplays a key role
in processing nociceptive information (Fields, 2000), directed us
to examine whether the reduced sensitivity to pain in the mutant
mice was linked to an opioid-mediatedmechanism. For this pur-
pose, a series of mice (n 10 per group) were pretreated with the
nonselective opioid receptor antagonist naloxone (1 mg/kg, i.p.)
30 min before performing the warm-water tail-immersion and
von Frey tests. After naloxone treatment, BAMBI/ mice
showed a normalization in the withdrawal response to both ther-
mal and mechanical stimuli, whereas no changes were evident in
wild-type mice; thus, both groups of animals became equally
responsive to pain (Fig. 3B,F). These results indicate that the
endogenous opioid system is involved in the reduced nocifensive
responses to painful stimuli displayed by BAMBI/mice under
basal conditions.
The anti-allodynic phenotype of BAMBI/mice involves
-opioid receptor activity
Fourteen days after sciatic nerve injury (Fig. 4, bottom), when
maximal differences in neuropathic pain-related behaviors be-
tween genotypes were evident, naloxone administration (n 10
per group) triggered mechanical hypersensitivity and allodynia in
BAMBI/mice but did not influence significantly the nocicep-
tive response in thewild-type group (genotype: F(1,69) 16.6, p
0.001; NLX treatment: F(1,69)  11.5, p  0.01; genotype  treat-
ment: F(1,69) 4.5, p 0.05). To further define the opioid recep-
tor subtype(s) responsible for theanti-allodynicphenotype, a series
of BAMBI/mice, subjected to sciatic nerve injury for 14 d, were
Figure 3. Responses to acute painful stimuli. A, Warm-water tail-flick assay assessed at 45,
47, and 49°C. B, Effect of the pretreatment with NLX (1 mg/kg, i.p.) on tail-flick latencies.
C, Hotplate licking and jump latencies at 50°C. D, Cumulative time spent licking the hindpaw
after subcutaneous injection of Formalin (20l of 2% Formalin) into the plantar surface from
0–5min (first phase) and 20–30min after injection (second phase). E, Mechanical stimulation
test (von Freymonofilaments). Values are the percentage of hindpawwithdrawals in response
to stimuli of increasing strength. F, Effect of NLX (1 mg/kg, i.p.) on the mechanical sensitivity
threshold. Note that, after naloxone treatment,BAMBI/mice showedanormalization in the
withdrawal response to both thermal and mechanical stimuli, whereas no changes were evi-
dent in wild-type mice. Data are means SEM. *p 0.05, **p 0.01, and ***p 0.001
versus BAMBI/mice (two-tailed Student’s t test).
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pretreated with selective antagonists of the different opioid receptor
types, 60 min before analyzing the development of mechanical hy-
persensitivity. Subsequently, mice received a dose of naloxone to
evaluate thedegreeof antagonismreachedwith eachdrug.As shown
in Figure 6, the -selective antagonist naltrindole fully reversed the
anti-allodynic phenotype (F(1,67)  490, p  0.001), whereas the
-opioid (-FNA;F(1,67)48.5,p0.001)and-opioid (nor-BNI;
F(1,67) 4.7, p 0.05) selective antagonists were barely effective.
Basal expression of POMCmRNA and protein, as well as
proenkephalin mRNA and the derived opioid peptide
Leu-enkephalin, is increased in BAMBI/ spinal cord
Given the regulatory function exerted by TGF-s on gene tran-
scription, we analyzed whether the spinal cord expression levels
of genes encoding endogenous opioid peptides was affected by
BAMBI deletion. Our results indicated that the basal level of
POMC mRNA, the gene codifying for -endorphin, was 2.46 
0.30-fold (95% confidence level, 1.63–3.29; p 0.022, two-tailed
t test) higher in the BAMBI/mice (n 5) than in the wild type
(n  5). We also observed a 1.64  0.11-fold increase (95%
confidence level, 1.32–1.97; p  0.007, two-tailed t test) in the
basal level of proenkephalin (PENK) mRNA, the gene codifying
for enkephalins, in BAMBI/ mice compared with wild-type
mice. Conversely, the basal level of prodynorphin (PDYN)
mRNA, the gene codifying for dynorphins, was similar in both
genotypes. To assess that increased transcription is translated to
the protein level, we determined by Western blot or RIA the
expression levels of the different opioid peptides. Spinal expres-
sion levels of POMC protein, determined by Western blot, and
Leu-enkephalin, measured by RIA, were higher in BAMBI/
than in wild-type mice (POMC: 43.8  11.9%, p  0.034;
PENK:44.2 9.0%, p 0.011). No differences between geno-
types were observed in the spinal cord concentration of dynor-
phin, measured by RIA (data not shown).
As shown in Table 1, the spinal cord expression levels of genes
encoding POMC, PENK, and PDYN were significantly and in-
versely related to BAMBI expression, whereas directly correlated
with the mRNA levels of various TGF- family members (TGF-
1, activin, and BMP-7) and with representative intracellular
Figure 4. Development of neuropathic pain in response to crush injury of sciatic nerve.
Representative graphs showing the behavioralmanifestations of neuropathic pain (mechanical
allodynia) evaluated with the von Frey monofilaments, on day 14 after nerve injury and the
effect of naloxone pretreatment before performing the von Frey test. Values are the mean
SEM percentage of hindpawwithdrawals elicited bymechanical stimuli of increasing strength,
in wild-type (top graph) and BAMBI/ (bottom graph) mice subjected to sham operation
(triangles) or sciatic nerve injury (circles). Two-wayANOVA indicates thatBAMBI/micewere
significantly less sensitive to mechanical stimuli compared with their wild-type littermates.
Naloxone treatment (filled circles) before performing themechanical test, on day 14 after nerve
injury triggered mechanical allodynia in BAMBI/ mice, whereas no significant changes in
mechanical sensitivity were evidenced in wild-type mice.
Figure 5. Development of neuropathic pain in response to spared nerve injury. Representa-
tive graphs showing the behavioral manifestations of neuropathic pain (mechanical allodynia)
evaluated with the von Frey monofilaments, on day 14 after SNI surgery in BAMBI/ (filled
circles) andwild-type (filled squares)mice. Values are themean SEMpercentage of hindpaw
withdrawals elicited by mechanical stimuli of increasing strength, in wild-type (triangles) and
BAMBI/ mice (circles), subjected to sham operation (open symbols) or SNI surgery (filled
symbols). Two-way ANOVA indicates that BAMBI/mice were significantly less sensitive to
mechanical stimuli compared with their wild-type littermates. Note also the difference in me-
chanical sensitivity between sham-operated BAMBI/ and BAMBI/mice.
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effectors from the TGF- canonical (common SMAD4) and al-
ternative (TAK1) signaling pathways (Wrana et al., 1994). These
results led us to test whether exogenously administered recombi-
nant TGF-s influence transcriptional regulation of POMC and
PENK under basal conditions. For this purpose, explanted spinal
cords from wild-type mice were cultured in the presence of re-
combinant activin A (20 ng/ml) or BMP-7 (20 ng/ml) for 1 h, and
POMC and PENK expression levels were assessed by quantitative
RT-PCR. Because the TGF-members acting physiologically on
the spinal cord remain to be identified, we selected activin A and
BMP-7 because they signal through the two differentmajor Smad
pathways in TGF- superfamily signaling: activin/TGF--
specific R-Smads (Smads 2 and 3) or BMP-specific R-Smads
(Smads 1, 5, and 8). One hour incubation of spinal cord explants
with activin A or BMP-7 significantly increased POMC mRNA
levels [activin A: 2.7-fold vs untreated (95% confidence level,
1.57–3.38; two-tailed t test, p 0.039); BMP-7: 1.74-fold vs un-
treated (95% confidence level, 1.63–1.84; two-tailed t test, p 
0.0001)]. Also, PENK mRNA levels increased significantly in
explants incubated with BMP-7 versus untreated (1.64-fold; 95%
confidence level: 1.32–1.97; two-tailed t test; p 0.0079).
Discussion
To unravel novel roles for TGF-s in the adult CNS, we have
examined the expression pattern and the function of BAMBI, a
pseudoreceptor thatmodulates negatively pan-TGF- family sig-
naling (Onichtchouk et al., 1999). We show that BAMBI tran-
scripts are abundant in several CNS areas critically involved in
pain processing (Fields, 2000; Todd and Koerber, 2006), such as
the cingulate cortex, the mesencephalic periaqueductal gray, and
the superficial laminae of the spinal cord dorsal horn. The pres-
ence of BAMBI protein and its preferential location in neurons
was confirmed on the former structure by immunohistochemis-
try. At the peripheral level, in the dorsal root ganglion, BAMBI
was also detected in virtually all sensory neurons but was absent
in their satellite glia. The location of BAMBI expression is indic-
ative of a role for TGF- family members in nociceptive regula-
tion, both central and peripherally. This suggestion is further
supported by a recent report showing the antiallodynic effect
exerted by recombinant TGF-1 in a rat model of neuropathic
pain (Echeverry et al., 2009). Thus, we aimed to assess possible
changes in the responsiveness to painful stimuli, under condi-
tions of enhanced TGF- signaling. This objective directed us to
develop a mutant mouse lacking BAMBI. As we expected, the
absence of the inhibitory influence of BAMBI in knock-out mice
resulted in increased levels of representative downstream effec-
tors of the TGF- signaling pathway, such as the phosphorylated
forms of Smad1 and Smad2 transcription factors, in some regions
of the CNS. Our first behavioral analyses was the absence in
BAMBI/ mice of phenotypic defects, affecting general motor
and sensory functions, which could constitute confounding fac-
tors to interpret pain behaviors. Nevertheless, it should be noted
that backcrossing to the sixth generation could be insufficient for
complete abolition of potential “hitchhiking donor gene” con-
founds (Gerlai, 1996).
Figure 6. Effects of specific opioid antagonists on neuropathic pain behavior in BAMBI/
mice. Representative graphs showing the behavioral manifestations of neuropathic pain (me-
chanical allodynia) evaluated with von Frey monofilaments, on day 14 after sciatic nerve crush
injury (triangles), and the effect of pretreatment with selective opioid antagonists before
4
performing the von Frey test (open circles). The antagonistic effect achieved by subsequent
naloxoneadministration is also shown(filled circles). Values are themeanSEMpercentageof
hindpaw withdrawals elicited by mechanical stimuli of increasing strength. The selective an-
tagonist of-opioid receptors, naltrindole (top graph), fully reversed the anti-allodynic pheno-
type of BAMBI/ mice, whereas the -opioid (-FNA) and -opioid (nor-BNI) selective
antagonists were much less effective.
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When acute pain paradigms were tested, we observed that the
absence of BAMBI conditioned lower nociception-related re-
sponses, regardless of the modality of the noxious stimuli used
(thermal, mechanical, and chemical/inflammatory). There was
gene-dosage dependence in the nocifensive responses to thermal
and mechanical stimuli, as indicated by the behavior of the het-
erocygotes. Thus, the nocifensive responses of BAMBI/ mice
to noxious stimuli are consistent with the hypothesized role for
TGF-s in controlling physiological pain perception under basal
conditions. Interestingly, the opioid antagonist naloxone was
able to reverse the pain-related behaviors of BAMBI/ mice to
that of wild-type controls, indicating that the hypoalgesia exhib-
ited by BAMBI/mice under basal conditions can be attributed
to an enhanced endogenous opioid tone.
In the chronic and pathological neuropathic pain model, our
results indicate that, in BAMBI/ mice, the release of TGF-
signaling from the inhibitory influence of BAMBI also attenuated
pain hypersensitivity and allodynia induced by sciatic nerve in-
jury over a follow-up period of 18 d. This anti-allodynic pheno-
type of BAMBI/mice was also evidenced in another model of
peripheral mononeuropathy, such as the spared nerve injury.
These results are in agreement with the aforementioned data
of Echeverry et al. (2009) showing that chronic (14 d) intra-
thecal infusion of recombinant TGF-1 prevented the devel-
opment of allodynia and reversed previously established
neuropathic pain in rats. The mechanism proposed by the
authors involves an inhibitory effect on the spinal cord inflam-
matory response to nerve injury exerted by TGF-1. In our
study, naloxone completely restored the attenuated allodynic
response of BAMBI/ mice to that of wild type, suggesting
that TGF- signaling is critical in controlling the expression of
abnormal nociceptive responses subsequent to nerve injury,
by a mechanism fully dependent on ongoing opioid receptor
activation. The results obtained with selective opioid antago-
nists indicate that the anti-allodynic phenotype is mainly de-
pendent on -receptor activity.
The expression of BAMBI in dorsal horn overlaps with several
type I receptors for TGF- family members, such as ALK-3,
ALK-4, andALK-6, suggesting a functional implication of TGF-
signaling in this region. It is well known that the dorsal horn of
the spinal cord is the zone in which nociceptive primary afferent
axons terminate, establishing the first synapse in the ascending
pathways that convey the sensory information from peripheral
receptors to the brain. It contains local neuronal circuits that are
involved in modulating incoming nociceptive information be-
fore its transmission up to the brain (Todd and Koerber, 2006).
The superficial laminae of the dorsal horn contains intrinsic opi-
oid inhibitory interneurons that express enkephalin, dynorphin,
and-endorphin and also receives afferent-endorphinergic in-
put from the arcuate and tractus solitarius nuclei (Tsou et al.,
1986; Fields, 2000). Under physiological conditions, these opioid
peptides exert an inhibitory control on the incoming nociceptive
through receptors located both presynaptically on nociceptor
terminals and postsynaptically on intrinsic dorsal horn neurons
(Yaksh et al., 1982; Kondo et al., 2005; Pasternak, 2005). Under
pathological conditions, the endogenous opioidergic system has
been reported to counteract the development of neuronal hyper-
excitability after intense noxious drive (Guan et al., 2006) and
neuropathic pain-related states after nerve injury (Hao et al.,
1998; Mansikka et al., 2004).
The precursors of endogenous opioid peptides are encoded by
three different genes: the PENK gene that is translated into the
protein precursor of enkephalins, the PDYN gene that encodes
dynorphins, and the POMC gene that gives rise to -endorphin.
Our results indicate that basal levels of POMCmRNAandPOMC
protein, as well as PENK gene and the opioid peptide enkephalin,
are higher in the spinal cords of BAMBI/mice than in those of
wild type. Furthermore, the spinal cord expression levels of genes
encoding precursor proteins of the opioid peptides directly cor-
related with members of the TGF- family and with their intra-
cellular effectors Smad4 andTAK1, whereas the relationshipwith
BAMBI was inversely proportional. These results suggest that an
increased transcriptional activity of endogenous opioids is likely
mediating the reduced nociceptive responses in the absence of
BAMBI. This interpretation is also supported by the transcrip-
tional regulatory effect exerted by recombinant BMP-7 and ac-
tivin A on POMC and PENK genes, in spinal cord explants. These
results are consistent with previous reports showing in vitro that
members of the TGF- family regulate the transcription of genes
coding for theendogenousopioidpeptides inavarietyofhumanand
rodent cell preparations (Kamphuis et al., 1997; Kavelaars and Hei-
jnen, 2000; Nudi et al., 2005), and in vivo (Bouret et al., 2001).
Many studies support an antinociceptive action of enkepha-
lins and -endorphin by negatively modulating transmission of
nociceptive information at the spinal level (Yaksh et al., 1982).
Furthermore, POMC and PENK gene delivery to spinal cord dor-
sal horn induces analgesia, which is associated with increased
production of -endorphin or enkephalin by specific subsets of
spinal neurons (Hao et al., 2003; Wu et al., 2004). In addition, it
has been demonstrated that mice deficient in PENK showed ex-
aggerated behavioral responses to painful stimuli (Ko¨nig et al.,
1996). Also, transgenic mice, with a selective deficiency of
-endorphin, lack the opioid-mediated (naloxone reversible) an-
algesia induced by stress (Rubinstein et al., 1996). Therefore, our
data suggest that hypoalgesic-related responses in mice lacking
BAMBI is attributable to an increased tonic activation of opioid
receptors by their endogenous ligands. Particularly, the anti-
allodynic phenotype is mainly dependent on -receptor signal-
ing, which would be consistent with the relatively high affinity of
enkephalins for this receptor (Dhawan et al., 1996).
Although our study was focused on spinal mechanisms, we can-
not exclude the contribution of supraspinal and peripheral mecha-
nisms in the altered pain processing displayed by BAMBI/mice.
In fact, BAMBI localization in dorsal root ganglion neurons and
the reduced pain behavior of BAMBI/ mice in the Formalin
test could point to a reduction in the excitability and postinjury
Table 1. Pearson’s correlation coefficient values (R) obtained from the linear regression analyses correlating spinal cordmRNA expression levels of TGF-1, BMP-2, BMP-7,
activin, SMAD4, TAK1, and BAMBI with the expression of genes encoding POMC, PENK, and PDYN
TGF-1 BMP-2 BMP-7 Activin SMAD-4 TAK-1
BAMBI
WTWT KO WT KO WT KO WT KO WT KO WT KO
POMC 0.65** 0.54* 0.47* 0.48* 0.57* 0.75*** 0.54* 0.72*** 0.30 0.67** 0.41 0.72*** 0.62*
PENK 0.76*** 0.65** 0.69** 0.65** 0.80*** 0.71*** 0.58* 0.63** 0.64** 0.80*** 0.73*** 0.70*** 0.51*
PDYN 0.71*** 0.72*** 0.75*** 0.80*** 0.68*** 0.83*** 0.61** 0.68** 0.39 0.68*** 0.45* 0.77*** 0.54*
WT, Wild type; KO, knock-out. *p 0.05, **p 0.01, and ***p 0.001.
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sensitization of primary sensory neurons (Tjølsen et al., 1992;
McNamara et al., 2007) that play important roles in the initiation
and maintenance of persistent pain.
Our present results and those of Echeverry et al. (2009) sug-
gest that members of the TGF- family modulate negatively pain
perception under physiological and pathological conditions.
However, the opposite response has been described for activin A
that is released during peripheral inflammation, acting on sen-
sory nerve terminals to increase the expression of calcitonin-gene
related peptide in dorsal root ganglion neurons and leading to
enhanced pain responses (Xu et al., 2005). In addition, subcuta-
neous injection of activin A induced immediate thermal hyper-
algesia in rats, through amechanism involving acute sensitization
of TRPV1, which suggests a role for activin A in injury-induced
hyperalgesia (Zhu et al., 2007). The extremely variable cellular
responses elicited by many TGF- superfamily members, de-
pending on cell type and stimulation context, could account for
these antagonic effects, and the contribution of each of these
mechanisms to nociception deserves further investigation.
In conclusion, the absence of BAMBI unravels a critical role
for TGF- signaling in nociceptive perception under physiolog-
ical and neuropathic pathological conditions, through a mecha-
nism involving transcriptional regulation of the opioid peptides.
Moreover, our results suggest that specific members of the
TGF- family, their signaling effectors, andmodulatormolecules
could be used as therapeutic targets for the design of novel anal-
gesic drugs that may act by increasing the activity of the endoge-
nous opioid system.
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